Deutsche Bank’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.91M | Buy |
140,789
+21,460
| +18% | +$746K | ﹤0.01% | 1170 |
|
|
2025
Q4 | $3.62M | Buy |
119,329
+97,210
| +439% | +$2.71M | ﹤0.01% | 1474 |
|
|
2025
Q3 | $425K | Buy |
22,119
+2,758
| +14% | +$40.9K | ﹤0.01% | 2641 |
|
|
2025
Q2 | $217K | Buy |
+19,361
| New | +$202K | ﹤0.01% | 2921 |
|
|
2020
Q2 | – | Sell |
-233
| Closed | -$8K | – | 4504 |
|
|
2020
Q1 | $8K | Buy |
233
+48
| +26% | +$2.61K | ﹤0.01% | 4090 |
|
|
2019
Q4 | $12K | Buy |
+185
| New | +$11.8K | ﹤0.01% | 4457 |
|
|
2018
Q2 | – | Sell |
-1,630
| Closed | -$175K | – | 5653 |
|
|
2018
Q1 | $175K | Buy |
1,630
+1,606
| +6,692% | +$431K | ﹤0.01% | 4257 |
|
|
2017
Q4 | $6K | Sell |
24
-386
| -94% | -$112K | ﹤0.01% | 4848 |
|
|
2017
Q3 | $101K | Buy |
410
+131
| +47% | +$46.6K | ﹤0.01% | 4165 |
|
|
2017
Q2 | $144K | Buy |
279
+65
| +30% | +$33.9K | ﹤0.01% | 4079 |
|
|
2017
Q1 | $117K | Buy |
214
+1
| +0.5% | +$558 | ﹤0.01% | 3842 |
|
|
2016
Q4 | $131K | Buy |
213
+38
| +22% | +$20.2K | ﹤0.01% | 3937 |
|
|
2016
Q3 | $106K | Hold |
175
| – | – | ﹤0.01% | 3921 |
|
|
2016
Q2 | $109K | Hold |
175
| – | – | ﹤0.01% | 4067 |
|
|
2016
Q1 | $130K | Hold |
175
| – | – | ﹤0.01% | 3862 |
|
|
2015
Q4 | $175K | Buy |
175
+59
| +51% | +$66.8K | ﹤0.01% | 3786 |
|
|
2015
Q3 | $124K | Buy |
116
+103
| +792% | +$157K | ﹤0.01% | 4005 |
|
|
2015
Q2 | $23K | Buy |
+13
| New | +$17.1K | ﹤0.01% | 4877 |
|
|
2014
Q1 | – | Sell |
-232
| Closed | -$589K | – | 5827 |
|
|
2013
Q4 | $589K | Buy |
232
+180
| +346% | +$415K | ﹤0.01% | 2990 |
|
|
2013
Q3 | $125K | Buy |
52
+44
| +550% | +$91.7K | ﹤0.01% | 4340 |
|
|
2013
Q2 | $16K | Buy |
+8
| New | +$24.4K | ﹤0.01% | 4823 |
|
Other funds holding ORKA
VA
FFM
PBA
RI
DTC
VCM
APM